Background: Rapid digital transformation is reshaping health care, but many digital initiatives struggle to deliver sustained organizational value when they are introduced as stand-alone technologies rather than as part of an institutional strategy. In Saudi Arabia, Vision 2030 has intensified pressure on academic medical centers to strengthen digital capability, localize innovation, and reduce dependence on externally driven solutions. Objective: This study aimed to examine organizational factors shaping digital health innovation at King Saud University Medical City (KSUMC) and to develop a preliminary strategic planning framework for a digital health innovation hub tailored to that setting. Methods: We conducted a qualitative exploratory case study at KSUMC between April and June 2025. Fourteen stakeholders from clinical, administrative, research, governance, educational, and innovation-related roles were recruited using maximum variation purposive sampling. Semistructured interviews were audio-recorded, transcribed verbatim, and analyzed using reflexive thematic analysis. Reporting was guided by the COREQ (Consolidated Criteria for Reporting Qualitative Research). Diffusion of innovation theory and systems thinking informed interpretation, while a context-actor-mechanism-outcome lens was used to examine how institutional conditions shaped innovation processes. No patient data were collected. Results: Five interrelated themes were identified. First, leadership support existed at a symbolic level, but middle-management translation and risk tolerance were inconsistent. Second, innovation was constrained by workload, fragmented systems, and weak operational support, which meant that project work was often treated as discretionary rather than embedded. Third, knowledge transfer and commercialization pathways were fragmented; participants repeatedly described unclear routes from idea generation to prototyping, regulatory review, and market engagement. Fourth, incentives and innovation capability were misaligned with institutional expectations, particularly for clinicians and trainees. Fifth, Vision 2030 created strategic legitimacy and momentum, but participants also cautioned that an overreliance on consultant-led or vendor-led approaches could weaken internal capability building. These findings informed a preliminary framework centered on governance, knowledge transfer, partnership structures, workforce development, and phased implementation rather than a validated institutional model. Conclusions: At KSUMC, digital health innovation is shaped not only by technology availability but also by organizational culture, intermediary structures, governance design, and the extent to which innovation work is made operationally feasible. The framework proposed here should therefore be understood as a preliminary planning model derived from one qualitative case study. Its main contribution is to specify how knowledge transfer, commercialization, and institutional capability building can be integrated into a digital health strategy within a Saudi academic medical center.
<img src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/85d230b912fdefe6673792b1fe27c5d2" />
A Self-Guided Mobile Mindfulness Intervention Embedded in Daily Routines for Adults With Mild to Moderate Psychological Distress: Randomized Controlled Trial
Background: Mobile mindfulness interventions have shown promise for reducing anxiety and depressive symptoms, but sustaining engagement remains a persistent challenge. Many digital programs still rely on formal practice that requires dedicated time, which may be difficult to integrate into daily life. Objective: This randomized controlled trial evaluated Habitual Mindfulness Practice (HMP), a self-guided mobile mindfulness intervention that embeds brief practices into recurring daily routines, among adults with mild to moderate psychological distress. Outcomes were compared with those of Traditional Mindfulness (TM), Mindfulness-Based Psychoeducation (MBP), and a waitlist control (WL). Methods: Adults aged 18 to 65 years with mild to moderate symptoms of anxiety or depression were randomly assigned in a 1:1:1:1 ratio to HMP, TM, MBP, or WL (N=686). All procedures were conducted online, and the intervention was fully self-guided, with outcomes assessed using self-report measures. The intervention lasted 21 days, with assessments conducted at baseline, postintervention, and 3-month follow-up. Primary outcomes were depressive and anxiety symptoms. Secondary outcomes included mindfulness, cognitive emotion regulation, affective balance, and interpersonal difficulties. Postintervention group differences were examined, controlling for baseline scores, and longitudinal trajectories were evaluated across the active intervention conditions. Results: At postintervention, significant group effects were observed for depressive symptoms (=28.67, <.001, ηp²=0.11) and anxiety symptoms (=30.11, <.001, ηp²=0.12). Both HMP and TM showed lower depressive and anxiety symptom scores than MBP and WL. TM showed lower postintervention anxiety than HMP (=.04), whereas depressive symptoms did not differ significantly between HMP and TM (=.63). The mindfulness practice conditions also showed more favorable postintervention outcomes for mindfulness, affective balance, interpersonal difficulties, and emotion regulation. Improvements in depressive and anxiety symptoms were generally maintained at follow-up among the active intervention conditions, although maintenance of secondary outcomes varied across measures. Postintervention outcome data were available for 55.2% (379/686) of randomized participants, and follow-up outcome data were available for 24.1% (124/515) of participants in the active intervention conditions. HMP and TM did not differ significantly in practice duration, engagement, or satisfaction. Conclusions: A routine-embedded, self-guided mobile mindfulness intervention may be a feasible approach for reducing mild to moderate psychological distress. HMP produced benefits broadly comparable to those of traditional app-delivered mindfulness, but it did not confer advantages in engagement or short-term efficacy. Trial Registration: Chinese Clinical Trial Registry ChiCTR2400093771; https://tinyurl.com/3d6tky8v
enDigital Postpartum Support for Early Risk Identification Among Postpartum Women: Formative Randomized Evaluation and Exploratory Predictive Modeling Study
Background: The postpartum period represents a critical window for maternal health, yet many individuals lack sustained support and timely identification of physical and mental health risks. Digital health interventions offer a scalable approach to extend care beyond clinical settings. Yet, key elements, including real-world challenges, usability, and effectiveness of such platforms, are insufficiently characterized in this literature. Objective: This study aimed to conduct a formative randomized evaluation to assess the feasibility, engagement, and preliminary signals of impact of the Joyuus platform and to examine the potential for early identification of postpartum health risks. Methods: We conducted a 12-week randomized evaluation with postpartum participants recruited through community-based organizations. Participants were randomized to either the Joyuus intervention or standard postpartum care. Primary and secondary outcomes included the Barkin Index of Maternal Functioning, the Edinburgh Postnatal Depression Scale (EPDS), the State-Trait Anxiety Inventory, and the Connor-Davidson Resilience Scale. Analyses were conducted using an intention-to-treat approach with linear regression models adjusting for baseline values. Engagement metrics (ie, sessions, time on site, and feature use) were captured through in-app analytics. An exploratory predictive model was developed using baseline clinical, behavioral, and demographic variables to identify individuals at risk for postpartum depression. Results: Baseline characteristics were generally balanced across arms, and no statistically significant differences were observed in education, income, or marital status. No statistically significant differences were found between treatment and control groups in the 12-week changes for the primary or secondary outcomes. Mean EPDS scores were 9.7 in the intervention group and 9.3 in the control group. In the sample, 60 (45.5%) of the 132 participants met the criteria for elevated depression (EPDS score ≥11 or a positive response to question 10 on self-harm), indicating a high burden of symptoms within the study population. Engagement with the platform was highest during the first 4 weeks. Among intervention participants, 80% created an account. Participants reported high levels of perceived usefulness, ease of use, and relevance of content. Qualitative analysis of open-ended survey responses highlighted limited awareness of postpartum-specific resources and a preference for simple, accessible information. An exploratory predictive model demonstrated a recall of 0.89 and a precision of 0.73 in identifying individuals at risk for postpartum depression, suggesting the feasibility of early risk identification using integrated data inputs. Conclusions: Joyuus demonstrated feasibility and acceptability but did not produce statistically significant improvements in maternal functioning or maternal health outcomes over 12 weeks. Joyuus identified high rates of depressive symptoms and early engagement patterns, which suggest an opportunity for earlier identification of risk and intervention during the postpartum period. Exploratory modeling results indicate the potential for data-driven approaches to support earlier detection. Future work includes optimizing engagement strategies and expanding validation of predictive detection to improve postpartum surveillance and outcomes. Trial Registration: ClinicalTrials.gov NCT05876559; https://clinicaltrials.gov/study/NCT05876559?cond=postpartum%20joyuus&viewType=Card&rank=1
STAT+: At key hearing, Kennedy’s ouster of former CDC director looms over nominee to replace her
The fates of two top health officials — Robert F. Kennedy Jr. and Susan Monarez — loomed over a Wednesday Senate hearing, though neither of them was in the room.
Almost a year after Kennedy ousted Monarez as director of the Centers for Disease Control and Prevention over vaccine policy, senators pressed the administration’s new pick to run the CDC on whether she’d face a similar fate, and how she’d deal with what many of them characterized as Kennedy’s political interference in the agency.
The nominee, Erica Schwartz, repeatedly demurred on the question, never quite saying whether she would stand up to the health secretary.
STAT+: New study untangles how Epstein-Barr viral infection triggers immune response in multiple sclerosis
In a new study published in Science Translational Medicine on Wednesday, researchers say they have uncovered how Epstein-Barr virus launches immune responses that lead to the inflammation and nervous system damage seen in people with multiple sclerosis.
“It’s very nice now to be able to understand more about the underlying mechanisms of how EBV likely causes MS,” said lead author Kjetil Bjornevik, an assistant professor of epidemiology and nutrition at the Harvard T.H. Chan School of Public Health. The findings, researchers hope, could help with the development of EBV vaccines or antiviral medications that could prevent or manage MS symptoms without the major side effects of commonly used immunosuppressants.
Syed Rizvi, the director of the Multiple Sclerosis Center of Rhode Island, who was not involved in this study, said the new findings help advance MS research toward more precise approaches. “When you’re developing drugs, targeted drugs, every little step, every little molecule, every little antigen is a game changer,” he said.
STAT+: Improvements in Alzheimer’s testing could make diagnostics more accessible, informative
This is the web edition of STAT’s AAIC in 30 newsletter.
Hello there from the final day of the Alzheimer’s Association International Conference. This is our last edition of this pop-up newsletter, but if you somehow haven’t tired of me, you can join me as well as my colleagues Damian Garde and Katherine MacPhail tomorrow to recap AAIC and discuss how the research presented here fits into the broader direction of the field. You can register for the virtual event here. It’s at 10 a.m. Eastern, 3 p.m. here in the U.K.
With next year’s AAIC set for Chicago, and as this nation descends into full World Cup mania in the coming hours, I’ll end by saying thanks for following along with me here in London.
How blood tests could reshape the future of identifying dementia
Traditionally, an Alzheimer’s diagnosis comes after a brain scan or spinal tap, or perhaps some cognitive tests administered by a behavioral neurologist. The tests can be burdensome, and specialist capacity is limited.
But research presented throughout the conference indicated how the field is moving in new directions, finding ways to make testing much more accessible, and offering more nuanced results that go beyond saying whether someone has Alzheimer’s or not.
In particular, blood-based biomarker tests that can help with diagnoses have started to come onto the market. The Alzheimer’s Association has also started to issue guidelines for how doctors should use them.
One study detailed here looked at whether these tests could be used in the primary care setting. Alzheimer’s experts say it’s crucial for more doctors to be able to diagnose the condition, particularly with the availability of new treatments that are more beneficial the earlier they can be used. Wait times for neurologists can extend for months, if not over a year.
Cassidy grills Trump nominee on past vaccine comments in heated exchange
WASHINGTON — Senate health leader Bill Cassidy (R-La.) grilled a Trump nominee for a key pandemic preparedness role over past comments in which he questioned vaccines, in a heated Senate confirmation hearing on Wednesday.
“Why would you repeat those damn lies? Because that destroys trust,” Cassidy said at one point to the nominee, Sean Kaufman, rapping his hand on the dais.
Meet GPT-Red: an LLM super-hacker OpenAI built to make its models safer
OpenAI has built an LLM super-hacker called GPT-Red that it uses as a sparring partner to help its other models boost their defenses against cyberattacks. Last week the company released the latest version of its flagship LLM, GPT-5.6. OpenAI says that training it against GPT-Red made the model its most robust release yet.
GPT-Red automates a type of safety evaluation for software systems known as red-teaming, which is typically done by a team of human testers. The aim is to find as many different ways to break or hijack a system as possible. The weak spots can then be patched before the final version of the software is released.
As LLMs become more complex and get used in a wider variety of tasks—especially in the form of agents, which can interact with computer files, websites, and third-party code as well as other agents—it’s hard for teams of people by themselves to keep up with all the types of attacks that might take place. “The risk surface grows and the blast radius also grows,” says Nikhil Kandpal, a research scientist at OpenAI who co-created GPT-Red.
OpenAI built GPT-Red to future-proof its safety testing process. “As more capable models become available, we will have already designed the system that can discover new modes of attack,” says Dylan Hunn, a research scientist at the company and fellow co-creator of GPT-Red. The researchers say it has already come up with new types of attack that had not been seen before.
OpenAI focused most of its efforts on a type of attack known as a prompt injection, where a hacker slips an LLM instructions to make it do things its developers or users do not want it to, such as copy confidential information, sabotage a company’s code base, or generate embarrassing or harmful output. In theory, such instructions can be hidden in any text that the LLM might encounter—in code or on a website, for example.
Training dojo
To build GPT-Red, OpenAI’s researchers took an LLM that had not been trained as a hacker and set it up in what’s known as a self-play loop with several other models. Its goal was to try to attack the other models; their goal was to try to defend themselves. Over many rounds of play, GPT-Red became better and better at attacking other LLMs, and those LLMs became better and better at fending off the attacks.
The training took place in a kind of dojo that OpenAI had designed to mimic a range of scenarios in which LLMs might be deployed in the real world, including browsing the web, reading emails or calendar apps, and editing code.
When GPT-Red found a new kind of attack, it would explore multiple different versions of it to find the most efficient one for specific scenarios. “Compared to a human red-teamer, the model is very, very good at finding exactly what will work, exactly what’s most effective,” says Hunn. “It’s extremely persistent about drilling down into an attack that it has discovered.”
In particular, OpenAI claims that GPT-Red found a type of prompt injection attack that the researchers had not seen before, which they call a fake chain of thought. A chain of thought is a kind of diary in which an LLM makes notes to itself and keeps track of partial results as it works through problems. GPT-Red found a way to insert a fake entry into another model’s chain of thought that would trick that model into acting on spoofed information.
“It’s like if I told you that 1+1=3 and that you have verified this already,” says Chris Choquette-Choo, another research scientist on the team. “The model’s like, ‘Oh, okay, of course,’ and it just spits out 3.”
Jessica Ji, a senior research analyst who works on AI security at Georgetown University’s Center for Security and Emerging Technology (CSET), thinks the self-play loop that OpenAI used is a good approach. “The results look very promising,” she says.
OpenAI tested how good an attacker GPT-Red was by rerunning an experiment from 2025 in which human red-teamers tried to find weaknesses in an earlier version of GPT-5. When GPT-Red was set the same task, it was more successful at finding effective attacks than the humans had been.
OpenAI also tested GPT-Red against Vendy, a vending machine agent developed by Andon Labs, a company that assesses how well agents perform real-world tasks. GPT-Red was able to hack Vendy to make it change the prices of items on sale and cancel a customer’s order.
Defensive behavior
OpenAI says that when it tried out some of the strongest attacks that GPT-Red had come up with on its models, more than 90% of them worked against GPT-5 (released in August last year), and fewer than 23% worked against the new GPT-5.6.
GPT-Red isn’t perfect. It is not great at figuring out attacks that involve a back-and-forth conversation between hacker and target, something that human attackers would have few problems with. It is also not yet that great at using images, which can be used to pass text to models in prompt injection attacks.
The company says that GPT-Red supplements the work of its human red-teamers. People can still find attacks it misses. One approach OpenAI is taking is to give GPT-Red an attack that humans came up with and ask it to find all the variations.
“I think human expertise will still be very important,” says CSET’s Ji. “It would be really useful to be able to distinguish where human testing is most needed.”
Unsurprisingly, OpenAI will not be releasing GPT-Red. The company is also confident that the super-hacker is stronger than any copycat model someone might try to create. The researchers say they have been working on the model for more than a year, backed by the compute resources of one of the richest companies in the world.
“It’s not a trivial thing that someone could easily do—you know, just go and train a super-attacker using this idea,” says Choquette-Choo.
Blood Test Foresees Decline into Alzheimer’s Disease
A blood-based biomarker could predict a person’s risk of developing Alzheimer’s disease years before any symptoms arise, research suggests.
Plasma levels of phosphorylated tau 217 (p‑tau217) may one day help identify at-risk individuals before overt signs of dementia, enabling the pre-emptive use of disease-modifying therapies.
Higher plasma p‑tau217 levels were associated with a greater risk of progressing to cognitive impairment in previously unaffected older adults, and they also predicted faster levels of decline.
The research findings appear in JAMA and were simultaneously presented this week at the annual Alzheimer’s Association International Conference in London.
“In this longitudinal study of several selected cohorts, plasma p-tau217 provided long-term prognostic information for individuals who were cognitively unimpaired at baseline, laying the groundwork for possible future development of individualized risk prediction scores,” proposed Rachel Buckley, PhD, from Mass General Brigham, and co-workers in their published work.
“By providing absolute risk estimates of progression to cognitive impairment, this article moves the field closer to presymptomatic risk stratification with p-tau217, supporting trial design.”
The large, pooled multicohort study included 2684 cognitively unimpaired older adults from six longitudinal studies, who were followed for a median of 5.4 years. Their median age was just short of 70 years, and 63% were women.
Results showed that higher baseline p-tau217 was significantly associated with an increased risk of progression to cognitive impairment during up to 13.5 years of follow up, with a hazard ratio of 1.38 per standard deviation (SD) increase.
This remained significant after accounting for age, sex, education, apolipoprotein E ε4 status, cohort, as well as amyloid positron emission tomography—known to accurately detect Alzheimer’s disease brain pathology.
The researchers report that the absolute risk of cognitive decline at five years was “meaningfully elevated” in the group with very high p-tau217 levels (≥2.5 SD) at 38%, versus just 12% in group with low levels.
Estimated 10-years risks were substantially higher at between 40% and 78% for the low and high p-tau217 groups, respectively. However, just 139 participants—or one in every 20—were followed up for at least a decade and the researchers say these risk estimates should be treated with caution.
Elevated p-tau217 was also associated with faster decline on the harmonized latent Preclinical Alzheimer Cognitive Composite assessment tool.
In an editorial accompanying the published study, Suzanne Schindler, PhD, from Washington University in St Louis school of medicine, and David Wolk, MD, from the University of Pennsylvania, note that cognitive impairment likely reflected multiple etiologies, not just Alzheimer’s disease.
“Indeed, even the low p-tau217 group, in which Alzheimer disease pathology was minimal or absent, still had a 12% risk of progression to cognitive impairment at five years, suggesting the importance of other drivers of cognitive decline in this population and the likelihood that in the higher p-tau217 groups, some proportion of individuals who declined may have primarily been driven by other processes,” they pointed out.
“Notably, discordance between plasma p-tau217 and amyloid PET (especially at intermediate or low amyloid levels) highlights that biomarkers beyond p-tau217 could further improve risk prediction.”
Nonetheless, overall they summarized: “The study by Buckley et al. represents a significant advance. It demonstrates that plasma p-tau217 can provide a time-specific absolute risk estimate for development of cognitive impairment.”
The post Blood Test Foresees Decline into Alzheimer’s Disease appeared first on Inside Precision Medicine.
BFRBs vs. OCD: Similarities and Differences
This blog was originally posted by the TLC Foundation for BFRBs
Body-focused repetitive behaviors (BFRBs) and obsessive-compulsive disorder (OCD) are two distinct mental health conditions that share some similarities but also have significant differences. BFRBs involve repetitive, self-grooming behaviors that can cause physical damage, such as hair pulling or skin picking. On the other hand, OCD is a condition characterized by intrusive thoughts (obsessions) and repetitive behaviors (compulsions) performed to alleviate anxiety.
While both conditions involve repetitive behaviors and can impact daily life, their underlying mechanisms, triggers, and treatment approaches differ. This article explores the key similarities and differences between BFRBs and OCD to better understand these complex conditions.
Similarities Between BFRBs and OCD
Most professionals view BFRBs and OCD as similar conditions due to the similarity in symptoms, such as compulsivity and repetitive behaviors. These two conditions share several similar systems and are usually a reaction to triggering factors such as stress and anxiety. Below are some of their similarities.
Repetitive Behaviors
Individuals dealing with BFRBs often engage in various repetitive behaviors such as hair pulling, lip biting, or skin picking. These actions are usually challenging to control and are frequently triggered by stress or anxiety. One may indulge in the habit subconsciously to find instant relief from the trigger.
Individuals with OCD often experience intrusive thoughts that result in repetitive behaviors known as compulsions. Some common compulsions include washing hands and repetitively checking or counting to alleviate the stress caused by obsessive thoughts. In both conditions, the repetitive behaviors are often exacerbated by stress and anxiety, and individuals may adapt these behaviors as a coping mechanism.
Impulse Control
Closely related to repetitive behaviors is the concept of impulse control. Both BFRBs and OCD involve challenges in this area, albeit in different ways. Individuals with BFRBs and OCD may find it hard to control the urge to perform repetitive behaviors. This is because these repetitive behaviors often relieve tension. Despite knowing the consequences of these behaviors, the desire to indulge in them is usually irresistible.
For example, individuals with BFRBs understand that hair pulling may affect their appearance, but they cannot refrain from doing it. OCD occurs as a result of intrusive thoughts whereby one believes that if they do not perform a specific action, the stressor won’t go away. These intrusive thoughts often cause anxiety, which can be eased by engaging in the said repetitive behavior.
Onset and Course
Having examined the behavioral aspects, let’s now consider how these conditions develop over time. The onset of these two conditions shares several similarities regarding age, triggers, and psychological mechanisms.
The onset of both conditions is usually during childhood or adolescence and often coincides with various developmental changes and stressors. For individuals with BFRBs, the repetitive behaviors alleviate stress and anxiety instantly. At the same time, for those with OCD, performing the compulsions temporarily relieves them from the stress caused by their intrusive thoughts. The cognitive patterns involve repetitive actions, intrusive thoughts, and a lack of impulse control. In BFRBs, the urge to engage in these repetitive behaviors can be intrusive and persistent, while in OCD, one’s obsessions create a sense of urgency, which leads to the adoption of compulsive actions.
Neurobiological Factors
To fully understand the similarities between BFRBs and OCD, we must delve deeper into their biological underpinnings. Both conditions have a genetic origin and are associated with neurobiological factors. Neurobiological studies indicate that the impulse control and emotional regulation difficulties for people with BFRBs and OCD are often caused by abnormalities in brain regions that are responsible for impulse control and habit formation. Therefore, the underlying brain mechanism may result in the onset and development of both conditions. It is not uncommon for individuals to have both BFRBs and OCD or for both conditions to coincide with other mental health conditions, usually depression and anxiety. The overlap is generally because they typically share common underlying factors that play a part in their severity and development.
Differences Between OCD and BFRBs
While BFRBs and OCD share several commonalities, it’s equally important to understand their distinct characteristics, from the symptoms to the underlying mechanisms. Let’s explore the key differences that distinguish these two conditions.
Nature of the Behavior
First and foremost, let’s examine how the behaviors associated with each condition differ in their fundamental nature. Individuals dealing with these two conditions adopt diverse behaviors as coping mechanisms for their triggers. In BFRBs, the behaviors adopted, such as trichotillomania (hair-pulling) or cheek-biting, usually result in physical harm. However, regardless of the consequences, one always feels relieved when picking their skin or pulling their hair.
OCD, on the other hand, involves a wide range of compulsions, from washing to organizing, checking, and counting. Compulsive behaviors are performed due to intrusive thoughts that make one think that if they fail to indulge in a specific behavior, they might get hurt, or there might be other negative consequences.
Presence of Obsessions
Another crucial distinction lies in the cognitive processes behind these behaviors. Generally, BFRBs do not involve obsessive thoughts. The primary focus on BFRBs is usually more on the physical behavior and not the fear of specific consequences.
However, the major characteristic of OCD is intrusive thoughts, which increase the urge to indulge in particular behaviors for relief. The thoughts are usually persistent with unwanted images that result in distress.
People with BFRBs DO NOT report that if they do not pick on their skin, something terrible will happen. Instead, they report that picking or pulling their hair helps relieve them from intense and negative emotions. These behaviors, therefore, serve a self-regulatory function, unlike in OCD, where the repetitive behavior calms them from their intrusive thoughts.
Triggers
The nature of triggers for each condition is closely related to the presence or absence of obsessions. The primary trigger in BFRBs is stress and anxiety, but for OCD, the main trigger is intrusive thoughts, which then result in anxiety. OCD and BFRBs triggers differ in several ways, often resulting in different outcomes. OCD triggers often result in one taking measures to prevent harm, while for BFRBs, one uses the adopted behaviors to regulate and manage intense emotions. The nature of thoughts is an essential distinguishing factor, seeing as OCD involves intrusive and obsessive thoughts that trigger specific behaviors adopted to prevent harm. The purpose of compulsions in OCD is to reduce the anxiety caused by the obsessive thoughts, while in BFRBs, the behaviors are for emotional relief.
Awareness
Beyond triggers, the level of conscious awareness also differentiates these two conditions. Those dealing with BFRBs usually find themselves biting their nails or even pulling their hair subconsciously. Individuals with OCD are generally aware of their intrusive thoughts and are compelled to adopt specific behaviors as a response to these thoughts. Individuals with OCD are often aware of their compulsions and understand when they are being irrational, but they are unable to control themselves. Compared to people with OCD, those with BFRBs often find their behaviors more rewarding than distressing.
Treatment
Finally, while both conditions may benefit from cognitive behavioral therapy, the specific approach to treatment varies significantly. For individuals with BFRBs, the focus is on behavior modification and awareness, achieved through habit reversal training. For OCD, the emphasis is often placed on exposure to anxiety-provoking thoughts to help an individual tolerate anxiety, which prevents compulsive behavior.
Bottom Line
While BFRBs and OCD can coexist, they are distinct disorders with unique manifestations despite sharing some similarities. The key distinctions between these conditions are evident in their underlying mechanisms and treatment approaches.
Both involve compulsive behaviors, but their purposes differ. BFRBs primarily serve as subconscious tools for emotional regulation. OCD compulsions are conscious attempts to alleviate anxiety and prevent perceived harmful consequences. BFRB behaviors often occur with limited conscious awareness, while OCD sufferers are typically more aware of their compulsive actions.
Both conditions can significantly affect daily functioning and social interactions.BFRBs may lead to physical injuries and lowered self-esteem due to visible effects. OCD can cause severe anxiety and time-consuming rituals that interfere with daily activities.BFRB treatment emphasizes behavior modification and awareness techniques, while OCD treatment often involves exposure therapy to reduce anxiety responses.
Understanding these distinctions is crucial for accurate diagnosis and effective treatment. While both conditions present challenges, with proper support and intervention, individuals with BFRBs or OCD can learn to manage their symptoms and improve their overall quality of life.
The post BFRBs vs. OCD: Similarities and Differences appeared first on International OCD Foundation.